The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Aptevo Therapeutics; Bluebird Bio; Celgene; Gilead Sciences; Juno Therapeutics; Nektar; Precision Biosciences
Research Funding - Juno Therapeutics; Nektar
Patents, Royalties, Other Intellectual Property - Juno Therapeutics
Factors associated with duration of response after CD19-specific CAR-T cell therapy for refractory/relapsed B-cell non-Hodgkin lymphoma.
 
Jordan Gauthier
Research Funding - Juno Therapeutics (Inst)
 
Alexandre V. Hirayama
Research Funding - Juno Therapeutics (Inst)
 
Kevin Anthony Hay
Travel, Accommodations, Expenses - Juno Therapeutics
 
Daniel Li
Employment - Juno Therapeutics
Stock and Other Ownership Interests - Juno Therapeutics
 
Alyssa Sheih
No Relationships to Disclose
 
Vicky Wu
No Relationships to Disclose
 
Jenna M. Voutsinas
No Relationships to Disclose
 
Sindhu Cherian
No Relationships to Disclose
 
Xueyan Chen
No Relationships to Disclose
 
Barbara S. Pender
No Relationships to Disclose
 
Reed M. Hawkins
No Relationships to Disclose
 
Aesha Vakil
Stock and Other Ownership Interests - Juno Therapeutics
 
Tinh-Doan Phi
No Relationships to Disclose
 
Rachel N. Steinmetz
No Relationships to Disclose
 
Stanley R. Riddell
Stock and Other Ownership Interests - Juno Therapeutics
Consulting or Advisory Role - Adaptive Biotechnologies; Cell Medica; NOHLA Therapeutics
Research Funding - Juno Therapeutics
Patents, Royalties, Other Intellectual Property - Juno Therapeutics
 
David G. Maloney
Honoraria - Janssen Scientific Affairs; Seagen
Research Funding - GlaxoSmithKline (Inst); Juno Therapeutics
 
Cameron Turtle
No Relationships to Disclose